Quia Pharma AB (publ) (STO:QUIA)

SolarWinds Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	0.46	4.37	5.57	8.73	3.74
Other Revenue	-	-	-	-	-0
Revenue	0.46	4.37	5.57	8.73	3.74
Revenue Growth (YoY)	-89.48%	-21.53%	-36.15%	133.49%	-16.28%
Cost of Revenue	0.13	2.2	2.24	8.2	6.73
Gross Profit	0.33	2.17	3.33	0.53	-2.99
Selling, General & Admin	12.31	13.82	15.72	15.88	20.61
Other Operating Expenses	-2.26	0	0.05	0.02	0.07
Operating Expenses	14	17.68	19.13	18.1	21.95
Operating Income	-13.67	-15.51	-15.79	-17.57	-24.93
Interest Expense	-0.27	-1.01	-4.3	-2.43	-2.78
Interest & Investment Income	0	0	-	-	-
EBT Excluding Unusual Items	-13.93	-16.52	-20.09	-20	-27.71
Asset Writedown	-19.45	-	-	-	-
Pretax Income	-33.38	-16.52	-20.09	-20	-27.71
Net Income	-33.38	-16.52	-20.09	-20	-27.71
Net Income to Common	-33.38	-16.52	-20.09	-20	-27.71
Shares Outstanding (Basic)	948	74	2	1	0
Shares Outstanding (Diluted)	948	74	2	1	0
Shares Change (YoY)	1173.14%	4105.13%	182.75%	51.66%	33.80%
EPS (Basic)	-0.04	-0.22	-11.34	-31.92	-67.07
EPS (Diluted)	-0.04	-0.22	-11.34	-31.92	-67.07
Free Cash Flow	-10.17	-10.27	-18.18	-20.19	-28.87
Free Cash Flow Per Share	-0.01	-0.14	-10.26	-32.22	-69.89
Gross Margin	72.17%	49.63%	59.81%	6.04%	-79.94%
Operating Margin	-2970.65%	-354.64%	-283.35%	-201.25%	-666.86%
Profit Margin	-7256.30%	-377.75%	-360.40%	-229.09%	-741.11%
Free Cash Flow Margin	-2211.09%	-234.70%	-326.12%	-231.27%	-772.21%
EBITDA	-11.49	-13.43	-13.98	-16.01	-23.67
EBITDA Margin	-	-	-250.79%	-183.37%	-
D&A For EBITDA	2.17	2.08	1.82	1.56	1.27
EBIT	-13.67	-15.51	-15.79	-17.57	-24.93
EBIT Margin	-	-	-283.35%	-201.25%	-
Revenue as Reported	2.83	4.39	5.58	8.73	3.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.